ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$8.21B
1-Year Return
14.38%
This Quarter Return
+5.58%
1 Year Return
+14.38%
3 Year Return
+47.96%
5 Year Return
+100.26%
10 Year Return
–
AUM
$6.42B
AUM Growth
+$1.45B
(+29%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
18.92%
Top 10 Holdings %
Top 10 Hldgs %
20.12%
Holding
3,007
New
984
Increased
562
Reduced
581
Closed
801
Top Buys
| 1 |
Microsoft
MSFT
|
+$463M |
| 2 |
Amazon
AMZN
|
+$346M |
| 3 |
Moderna
MRNA
|
+$70.9M |
| 4 |
Linde
LIN
|
+$43.9M |
| 5 |
DTE Energy
DTE
|
+$41.1M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$63.7M |
| 2 |
Comcast
CMCSA
|
+$40.5M |
| 3 |
Evergy
EVRG
|
+$37.2M |
| 4 |
Public Service Enterprise Group
PEG
|
+$37.1M |
| 5 |
Bio-Techne
TECH
|
+$33M |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Financials | 9.65% |
| 4 | Industrials | 9.54% |
| 5 | Healthcare | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Sabesp
SBS
$16B
| $125K | ﹤0.01% |
+16,911
| New | +$125K |
|
|
CBAY
2027
DELISTED
Cymabay Therapeutics
CBAY
| $125K | ﹤0.01% |
28,719
+10,980
| +62% | +$47.8K |
|
|
APTO
2028
DELISTED
Aptose Biosciences, Inc.
APTO
| $123K | ﹤0.01% |
+82
| New | +$123K |
|
2029
Marker Therapeutics
MRKR
$12.4M
| $122K | ﹤0.01% |
4,376
+3,298
| +306% | +$91.9K |
|
2030
BlackSky Technology
BKSY
$684M
| $121K | ﹤0.01% |
+1,516
| New | +$121K |
|
2031
Rithm Capital
RITM
$6.57B
| $121K | ﹤0.01% |
+11,442
| New | +$121K |
|
|
IMBI
2032
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $121K | ﹤0.01% |
+15,034
| New | +$121K |
|
2033
EyePoint Pharmaceuticals
EYPT
$920M
| $120K | ﹤0.01% |
13,400
-39,156
| -75% | -$351K |
|
2034
Mustang Bio
MBIO
$11.4M
| $120K | ﹤0.01% |
48
+4
| +9% | +$10K |
|
|
GRTS
2035
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $120K | ﹤0.01% |
13,093
-2,800
| -18% | -$25.7K |
|
2036
Harvard Bioscience
HBIO
$19.7M
| $119K | ﹤0.01% |
+14,256
| New | +$119K |
|
2037
Ondas Holdings
ONDS
$1.84B
| $119K | ﹤0.01% |
15,004
-1,596
| -10% | -$12.7K |
|
|
MTEM
2038
DELISTED
Molecular Templates, Inc.
MTEM
| $119K | ﹤0.01% |
1,018
-249
| -20% | -$29.1K |
|
2039
Solid Biosciences
SLDB
$420M
| $118K | ﹤0.01% |
2,146
+592
| +38% | +$32.6K |
|
|
TCDA
2040
DELISTED
Tricida, Inc. Common Stock
TCDA
| $118K | ﹤0.01% |
+27,220
| New | +$118K |
|
|
NYMX
2041
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $117K | ﹤0.01% |
+73,781
| New | +$117K |
|
2042
Alset
AEI
$103M
| $116K | ﹤0.01% |
+1,017
| New | +$116K |
|
|
AFMD
2043
DELISTED
Affimed
AFMD
| $116K | ﹤0.01% |
+1,361
| New | +$116K |
|
2044
Beyond Air
XAIR
$12.7M
| $116K | ﹤0.01% |
+895
| New | +$116K |
|
2045
Altimmune
ALT
$321M
| $115K | ﹤0.01% |
11,641
-65,007
| -85% | -$642K |
|
|
SCPS
2046
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
| $115K | ﹤0.01% |
+16,069
| New | +$115K |
|
2047
Urban One Class A
UONE
$63.1M
| $113K | ﹤0.01% |
+13,048
| New | +$113K |
|
2048
UWM Holdings
UWMC
$1.5B
| $113K | ﹤0.01% |
+13,362
| New | +$113K |
|
2049
VirnetX
VHC
$74.7M
| $113K | ﹤0.01% |
1,329
-1,141
| -46% | -$97K |
|
|
CSLT
2050
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $111K | ﹤0.01% |
42,095
-295,900
| -88% | -$780K |
|